Truist Financial Corp Ab Cellera Biologics Inc. Transaction History

Truist Financial Corp

  • $62.9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 01, 2023
SELL
$5.66 - $7.59 $89,999 - $120,688
-15,901 Reduced 22.87%
53,638 $346,000
Q1 2023

May 05, 2023
BUY
$7.31 - $11.18 $131,550 - $201,195
17,996 Added 34.91%
69,539 $524,000
Q4 2022

Feb 17, 2023
BUY
$9.48 - $14.52 $488,627 - $748,404
51,543 New
51,543 $522,000

Others Institutions Holding ABCL

# of Institutions
153
Shares Held
109M
Call Options Held
153K
Put Options Held
194K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $787M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email